Global Breast Cancer Incidence in Women
Approximately 2.3 million women are diagnosed with breast cancer worldwide each year 1, 2, 3, 4.
Current Global Burden (2022-2023 Data)
The most recent and highest-quality evidence from the Global Burden of Disease Study 2023 reports 2.30 million new breast cancer cases among females globally in 2023 (95% uncertainty interval: 2.01 to 2.61 million) 3. This figure is corroborated by multiple independent sources:
- 2.3 million new cases in 2022 according to Nature Medicine's analysis across 185 countries 4
- 2.3 million cases in 2022 per the British Journal of Cancer systematic review 1
- Over 2.3 million cases diagnosed annually as cited in the 2025 St. Gallen Consensus Statement 2
Regional Variation
The burden varies dramatically by geography and economic development:
- Incidence rates range from <40 per 100,000 women in some Asian and African countries to >80 per 100,000 in Australia/New Zealand, Northern America, and parts of Europe 5
- Belgium has the highest age-standardized incidence rate at 112.3 per 100,000 6
- Iran has among the lowest at 35.8 per 100,000 6
Socioeconomic Disparities
The relationship between development and breast cancer shows striking patterns 3:
- Very high HDI regions: 10.37% lifetime risk of developing breast cancer
- High HDI regions: 4.42% lifetime risk
- Medium HDI regions: 2.96% lifetime risk
- Low HDI regions: 2.91% lifetime risk
However, mortality patterns are inverted—low-income countries have the highest age-standardized mortality rate (24.1 per 100,000) despite having the lowest incidence rate (44.2 per 100,000), reflecting profound inequities in access to diagnosis and treatment 3.
Temporal Trends
Incidence is rising globally, particularly in transitioning economies 3, 4, 6:
- Low-income countries experienced a 147.2% increase in age-standardized incidence rates between 1990-2023 3
- High-income countries showed only a 1.2% change during the same period 3
- China and South Korea demonstrate significant increasing trends (AAPC ranging from 0.17% to 5.84%) 6
- The United States showed decreasing incidence during 2000-2012 6
Future Projections
By 2050, global incident cases are forecast to reach 3.56 million annually (range: 2.29 to 4.83 million), representing a 38% increase from 2022 levels 3, 4. This increase is driven primarily by population growth and aging, with the burden disproportionately affecting low- and middle-income countries 5.
Clinical Context
Breast cancer represents 11.6% of all cancer diagnoses globally and is the most commonly diagnosed cancer among women 1. Approximately one in four cancer cases among women is breast cancer 7. The lifetime risk of developing breast cancer globally is 5.51% (approximately 1 in 18 women), with 1.82% dying from the disease (approximately 1 in 55 women) 8.
Age Distribution
- Approximately 25% of cases occur before age 50 7
- Less than 5% occur before age 35 7
- Peak age varies by region, with some Asian and African countries experiencing peak incidence over 10 years earlier than European or American countries 6
Key Caveat
These figures represent newly diagnosed cases per year, not prevalent cases. The 5-year prevalence (people alive with a diagnosis within the last 5 years) was estimated at 6.875 million cases worldwide in 2018 7, reflecting improved survival rates due to advances in early diagnosis and treatment.